Business Context and Reporting Period
Company: Equus II Incorporated (a Delaware corporation and Business Development Company)
Reporting Period: Quarterly period ended September 30, 2000 (Nine months ended September 30, 2000)
Business Overview: The Fund seeks capital appreciation by investing in equity and equity-oriented securities of privately-owned companies, including leveraged buyouts and recapitalizations. It provides significant managerial assistance to 86% of its portfolio value.
Key Financial Metrics
| Metric | 9 Months Ended Sep 30, 2000 | 9 Months Ended Sep 30, 1999 |
|---|---|---|
| Total Assets | $170,165,759 | $175,022,415 |
| Net Assets | $90,521,218 | $101,418,820 |
| Net Assets Per Share | $15.75 | $16.61 |
| Total Investment Income | $4,132,682 | $3,704,102 |
| Total Expenses | $3,282,865 | $4,046,387 |
| Net Investment Income | $849,817 | $(342,285) |
| Realized Gains on Sales | $4,744,369 | $30,405,864 |
| Unrealized Depreciation | $(13,067,715) | $(34,433,420) |
| Total Decrease in Net Assets from Operations | $(7,473,529) | $(4,369,841) |
| Cash and Cash Equivalents | $60,047,176 | $35,049,509 |
| Notes Payable to Bank | $78,800,000 | $72,400,000 |
Material Changes vs. Prior Period
- Net Asset Decline: Net assets decreased by approximately $10.9 million (10.7%) from the beginning of the period, driven primarily by unrealized depreciation of portfolio securities ($13.1 million) and share repurchases ($3.8 million).
- Investment Income vs. Expenses: The Fund returned to positive net investment income ($849,817) compared to a loss of $(342,285) in the prior year. This improvement was due to a significant reduction in interest expense ($1.35M vs $1.83M) and professional fees, offset by lower management fees due to reduced net assets.
- Realized Gains: Realized gains dropped significantly to $4.7 million from $30.4 million in the prior year. The 2000 gains were largely attributable to additional compensation from escrow accounts on prior sales rather than new portfolio exits.
- Portfolio Valuation: The portfolio securities fair value decreased to $105.9 million from a cost basis of $120.1 million, resulting in a net unrealized depreciation of $14.2 million.
Guidance, Outlook, Risks, and Unusual Items
- Subsequent Events & Risks: Significant losses occurred after the reporting period. Drypers Corporation (DYPR) and Paracelsus Healthcare Corporation (PLS) filed for Chapter 11 bankruptcy. The Fund realized capital losses of $7.3 million on DYPR and $0.97 million on PLS. Additionally, the Fund wrote off $7.6 million related to The Drilltec Corporation.
- Dividends: In November 2000, the Fund declared a dividend of $0.60 per share, the majority of which is a return of capital. A prior dividend of $0.13 per share (undistributed capital gains and income from 1999) was declared in August 2000 for distribution in December 2000.
- Stock Repurchases: The Fund repurchased 167,700 shares during the period at an average discount of 36.8% from net asset value. An additional 65,700 shares were repurchased subsequent to the period end.
- Liquidity: The Fund maintains a $32.5 million revolving line of credit (with $18.8 million outstanding) and a $100 million promissory note line (with $60 million outstanding, largely repaid in October 2000). Management believes liquidity is sufficient to meet commitments and expenses.
- Commitments: The Fund has committed to invest up to an additional $6.5 million in five portfolio companies.
Investor Verification Checklist
- Subsequent Losses: Verify the impact of the post-period write-offs (Drilltec, DYPR, PLS) on the current portfolio valuation and future NAV.
- Debt Structure: Confirm the status of the $78.8 million in bank notes payable and the terms of the revolving credit facilities, particularly given the recent repayment of $62.5 million post-period.
- Officer Notes: Review the $10.1 million in notes receivable from officers (secured by pledged shares) which are excluded from the reported Net Asset Value per share.
- Dividend Composition: Confirm the tax treatment of the declared $0.60 dividend, specifically the portion classified as a return of capital.
- Portfolio Concentration: Assess the risk exposure to the 12 portfolio companies in which the Fund holds a controlling interest, as these are subject to appraisal valuation subjectivity.